2014 FDA Drug Approvals at 18-year High, but How Much New Ground Are We Breaking?
As the New Year bells chimed in 2015, the curtains drew shut on this century’s best year for novel-drug approvals. The…Read More
The J.P. Morgan Healthcare Conference: Worth the Fuss?
Attendance is by invitation only. There’s no trade show floor. And, good luck tracking down information on speakers and schedules if…Read More
Rare Diseases: The Role of Social Media in Patient Recruitment
Since the passing of the Orphan Drug Act in 1983, the rate of drug development in the United States has seen…Read More
Lab Tools and Ancient Sea Life: Medicine’s Lust for a Crab’s Blood
In the pharmaceutical and biomedical industries, the horseshoe crab is nothing short of a celebrity. If you haven’t heard about this…Read More
Usability: Making Better Websites with Dead Simple User Experience
Let’s get something straight: We’re all marketing to humans. Yes, customers’ perspectives, experiences and industries may differ — even within the…Read More
Replacing Adderall: Medicines to Change the World (Part I)
It’s a sad beginning to my series on medications set to change society and the way we live our lives. Shares…Read More